Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Investors who lost money in KD after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Investors who lost money in VRNS after its stock plunged 48% due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Investors who lost money in ARDT after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Investors who lost money in RR after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Investors who lost money in BRBR after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Investors who lost money in CRWV after its stock plunged 34% due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Investors who lost money in FFIV after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Investors who lost money in CPNG after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
LOS ANGELES, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Ultragenyx Pharmaceutical, Inc., (“Ultragenyx” or the "Company") (NASDAQ: RARE) investors of a class action on behalf of...
-
LOS ANGELES, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PomDoctor Ltd., (“PomDoctor” or the "Company") (NASDAQ: POM) investors of a class action on behalf of investors that...